Evidence map›Paper›PMID 30216974›Full record

ReviewMolecules (Basel, Switzerland)2018

Therapeutic Potential of Brazilian Cerrado

Carla Maiara Lopes Cardozo, Aline Carla Inada, Gabriela Marcelino, Priscila Silva Figueiredo, Daniela Granja Arakaki, Priscila Aiko Hiane, Claudia Andrea Lima Cardoso, Rita de Cássia Avellaneda Guimarães, Karine de Cássia Freitas

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 23 citations in OpenAlex.

  1. Effect of Supplementation with Hydroethanolic Extract ofMolecules (Basel, Switzerland) · 2020
    Article
  2. Antidiabetic Potential ofThe Yale journal of biology and medicine · 2020
    Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Carla Maiara Lopes CardozoPost Graduate Program in Health and Development in the Central-West Region of Brazil, Federal University of Mato Grosso do Sul-UFMS, Campo Grande 79070-900, MS, Brazil. carlinhalopescardozo@hotmail.com.
Aline Carla InadaPost Graduate Program in Health and Development in the Central-West Region of Brazil, Federal University of Mato Grosso do Sul-UFMS, Campo Grande 79070-900, MS, Brazil. inadaaline@gmail.com.
Gabriela MarcelinoPost Graduate Program in Health and Development in the Central-West Region of Brazil, Federal University of Mato Grosso do Sul-UFMS, Campo Grande 79070-900, MS, Brazil. gabi19ac@gmail.com.
Priscila Silva FigueiredoPost Graduate Program in Health and Development in the Central-West Region of Brazil, Federal University of Mato Grosso do Sul-UFMS, Campo Grande 79070-900, MS, Brazil. pri.figueiredo92@gmail.com.
Daniela Granja ArakakiPost Graduate Program in Health and Development in the Central-West Region of Brazil, Federal University of Mato Grosso do Sul-UFMS, Campo Grande 79070-900, MS, Brazil. daniarakaki@gmail.com.
Priscila Aiko HianePost Graduate Program in Health and Development in the Central-West Region of Brazil, Federal University of Mato Grosso do Sul-UFMS, Campo Grande 79070-900, MS, Brazil. priscila.hiane@ufms.br.ORCID 0000-0003-1115-4083
Claudia Andrea Lima Cardoso
Rita de Cássia Avellaneda GuimarãesPost Graduate Program in Health and Development in the Central-West Region of Brazil, Federal University of Mato Grosso do Sul-UFMS, Campo Grande 79070-900, MS, Brazil. claudia@uems.br.
Karine de Cássia FreitasPost Graduate Program in Health and Development in the Central-West Region of Brazil, Federal University of Mato Grosso do Sul-UFMS, Campo Grande 79070-900, MS, Brazil. kcfreitas@gmail.com.
Universidade Federal de Mato Grosso do Sul · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity, in conjunction with other metabolic disorders such as insulin resistance and dyslipidemia, is a feature of metabolic syndrome which is characterized by a pro-inflammatory state and increased oxidative stress. Therefore, antioxidant foods are proposed to prevent and treat these disorders. Medicinal plants are one of the main strategies in this regard. Guavira, a Brazilian Cerrado plant, contains different bioactive compounds with a high antioxidant capacity and without clinical or reproductive toxicity effects. Though there are different varieties of guavira, the principal Brazilian Cerrado guaviras demonstrated hypoglycemic, anti-inflammatory, and hypocholesterolemic actions. There is also a potential antiplatelet agent in

Indexed as

AnimalsAnti-Inflammatory AgentsAntioxidantsClinical Trials as TopicHumansHypoglycemic AgentsMetabolic SyndromeMyrtaceaePlant ExtractsPlatelet Aggregation InhibitorsAnti-Inflammatory AgentsAntioxidantsHypoglycemic AgentsPlant ExtractsPlatelet Aggregation InhibitorsBrazilian CerradoCampomanesia speciesmedicinal plantsobesity-induced metabolic syndrome

Identifiers

PMID30216974
PMCPMC6225494
OpenAlexW2891923546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.